Details
Product Name in the RMS: Addaven
MR Number: SE/H/1449/001
Date of outcome: 23.02.2015
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Known Active Substance Additional Strength/Form Bibliographic Chemical Substance Prescription Only |
Active Substances |
chromium(III)chloride hexahydrate 5,33 µg COPPER CHLORIDE dihydrate 0,1 mg FERRIC CITRATE hexahydrate 0,54 mg MANGANESE CHLORIDE tetrahydrate 19,8 µg potassium iodide 16,6 µg sodium fluoride 0,21 mg sodium molybdate 4,85 µg sodium selenite hydrate 17,3 µg zinc chloride 1,05 mg |
Form | Concentrate for solution for infusion |
MA Holder in the RMS | Fresenius Kabi AB |
RMS | Sweden |
Date of last change | 02.09.2020 |
ATC-Code |
B05XA31 Electrolytes in combination with other drugs |
CMS Country | Domestic Product Name |
---|---|
Austria | Addaven Konzentrat zur Herstellung einer Infusionslösung |
Bulgaria | Addaven |
France | |
Germany | Addaven Konzentrat zur Herstellung einer Infusionslösung |
Hungary | ADDAVEN koncentrátum oldatos infúzióhoz |
Luxembourg | |
Poland | Supliven |
Documents | |
---|---|
PAR: | https://www.lakemedelsverket.se/LMF/Lakemedelsinformation/?nplid=20130307000015 (22.04.2015) |
PARSummary: | https://www.lakemedelsverket.se/LMF/Lakemedelsinformation/?nplid=20130307000015 (22.04.2015) |